Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.

Eliot A Brinton, Uma Kher, Sukrut Shah, Christopher P Cannon, Michael Davidson, Antonio M Gotto, Tanya B Ashraf, Christine McCrary Sisk, Hayes Dansky, Yale Mitchel, Philip Barter

    Research output: Contribution to journalOriginal Articlepeer-review

    20 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)65-71
    JournalJOURNAL OF CLINICAL LIPIDOLOGY
    Volume9
    Issue number1
    DOIs
    Publication statusPublished - 2015

    Cite this